Seegene Inc (096530) - Medical Equipment - Deals and Alliances Profile
- GDME23818D
- Pages: 27
- October 2018
- Total Views:1156
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene's IVD reagents are used in testing respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company caters to commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It has operations in the US, Canada, Germany and others. Seegene is headquartered in Seoul, South Korea.
Seegene Inc (096530)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Inc, Medical Equipment, Deal Details 10
Partnerships 10
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc-Key Competitors 21
Seegene Inc-Key Employees 22
Seegene Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Product News 24
Jan 03, 2018: Seegene develops world's first multiplex MDx assays with its AI system 24
Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 25
Feb 14, 2017: Seegene Develops New Normalization Software Technology for Molecular Diagnosis 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Seegene Inc, Medical Equipment, Key Facts, 2017 2
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc, Key Competitors 21
Seegene Inc, Key Employees 22
Seegene Inc, Other Locations 23
Seegene Inc, Subsidiaries 23
Seegene Inc, Joint Venture 23
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Seegene Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene's IVD reagents are used in testing respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company caters to commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It has operations in the US, Canada, Germany and others. Seegene is headquartered in Seoul, South Korea.
Seegene Inc (096530)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Inc, Medical Equipment, Deal Details 10
Partnerships 10
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc-Key Competitors 21
Seegene Inc-Key Employees 22
Seegene Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Product News 24
Jan 03, 2018: Seegene develops world's first multiplex MDx assays with its AI system 24
Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 25
Feb 14, 2017: Seegene Develops New Normalization Software Technology for Molecular Diagnosis 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Seegene Inc, Medical Equipment, Key Facts, 2017 2
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc, Key Competitors 21
Seegene Inc, Key Employees 22
Seegene Inc, Other Locations 23
Seegene Inc, Subsidiaries 23
Seegene Inc, Joint Venture 23
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Seegene Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.